We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

1 hedge funds and large institutions have $72K invested in Heron Therapeutics in 2013 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
EEG
1
E.E. Geduld
$72K +$72K +10,000 New

HRTX Hedge Fund Activity: Q2 2013 in Review

1 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q2 2013, worth a combined $72K.

Buyers outnumbered sellers: 1 fund opened new HRTX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held Heron Therapeutics (HRTX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $72K of Heron Therapeutics stock for Q2 2013.
  • 1 fund opened new Heron Therapeutics positions in Q2 2013 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q2 2013.